K

KRMD

KRMD

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
58%Neutral
Buy/Sell Ratio100% buys
BearishBullish
KRMD Live QuoteReal-time
$3.44
+$0.33(+10.61%)1M
Day Range$3.35 – $3.58
Open$3.55
Previous Close$3.45
Volume203.7K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$149.21M
P/E Ratio (TTM)24.5
Forward P/E57.5
EPS (TTM)$-0.02
Price to Book7.7
Dividend Yield0.65%
Beta (Volatility)0.52
IndustryMEDICAL INSTRUMENTS & SUPPLIES
52-Week RangeCurrent: $3.44 (15%)
Low: $2.86High: $6.61
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$6.12-95.9% upside

Insider Buys

7

$216K

Insider Sales

0

$0

Total Volume

$216K

12 transactions

Net Activity

+$216K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
100CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Cluster buying: 5 unique insiders purchased shares, showing strong alignment.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys5 sells

$22.62B total

K
2

Kalbermatten Adam R

Chief Commercial Officer

2 buys0 sells

$150K total

A
3

Adams Thomas Edward

CFO

1 buys0 sells

$21K total

S
4

Schiller Eric

CTO

1 buys0 sells

$20K total

P
5

Pazdan Christopher

COO

1 buys0 sells

$19K total

Trading History
KRMD insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 8, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell394.0K$32000.00$12.61B

Sep 8, 2026

2 months ago

Kalbermatten Adam R

Chief Commercial Officer

C-Level
Buy32.0K$3.16$101K

Jun 11, 2026

5 months ago

Kalbermatten Adam R

Pres-Chief Commercial Off

President
Buy12.5K$3.94$49K

Jun 11, 2026

5 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell617.5K$12500.00$7.72B

May 15, 2026

6 months ago

Tharby Linda M

CEO

CEO
Buy1.2K$1.00$1K

May 15, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell620.6K$1191.00$739.16M

May 18, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell5.0K$5000.00$25.00M

May 18, 2026

6 months ago

Schiller Eric

CTO

CTO
Buy5.0K$3.91$20K

May 15, 2026

6 months ago

Tharby Linda M

CEO

CEO
Buy1.2K$3.92$5K

May 14, 2026

6 months ago

Adams Thomas Edward

CFO

CFO
Buy5.5K$3.86$21K

May 14, 2026

6 months ago

Pazdan Christopher

COO

COO
Buy5.0K$3.88$19K

May 14, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell305.1K$5000.00$1.53B
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
KRMD Buy Conviction100%
Industry Rank#0 of 570
Volume Contribution0.0%
Total Industry Activity$16.52B

KRMD has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for KRMD

Over the last 90 days, corporate insiders at KRMD (KRMD) engaged in a total of 12 transactions reported via SEC Form 4 filings. Among these, 7 were open-market purchases and 0 were sales. The total volume of insider trading reached $216K.

The net insider activity for KRMD shows a net buying bias of $216K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 394.0K shares valued at $12.61B on Sep 8, 2026.

Live Market News & Developments
Aggregated real-time headlines for KRMD (KRMD)
6 updates

KORU Medical Systems, Inc. (KRMD) Presents at Craig-Hallum 17th Annual Alpha Select Conference - Slideshow

Seeking Alpha15h ago

KORU Medical Systems, Inc. (KRMD) Q2 Earnings and Revenues Beat Estimates

Yahoo Finance107d ago

A fund reports 4.33 million shares in KORU Medical Systems (KRMD).

Stock Titan3d ago

KORU Medical Systems (KRMD) Stock Forum and Discussion

Moomoo104d ago

KORU Medical Systems (NasdaqCM:KRMD) Stock Forecast & Analyst Predictions

Simply Wall St8d ago

KORU Medical Q3 Revenue Rises 11% to $11.6 Million

Quiver Quantitative9d ago

FAQs About KRMD Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for KRMD.

Based on SEC Form 4 disclosures, the Insider Confidence Score for KRMD is currently 100/100, which reflects a strong accumulation bias. This calculation accounts for a total of 7 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for KRMD is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.